Literature DB >> 17467059

Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression.

Marc B J Blom1, Philip Spinhoven, Tonko Hoffman, Kosse Jonker, Erik Hoencamp, P M Judith Haffmans, Richard van Dyck.   

Abstract

BACKGROUND: Prediction of treatment outcome has important clinical consequences. Personality factors have rarely been tested as predictors of acute outcome. Personality, demographic and illness-related characteristics were assessed at baseline for prediction of outcome of treatment in depressed out-patients.
METHODS: One hundred and ninety-three patients with major depressive disorder (MDD) were enrolled in a 12 to 16 week trial. The treatment consisted of nefazodone, nefazodone in combination with interpersonal psychotherapy (IPT), IPT in combination with placebo and IPT alone. Demographic and illness related variables were collected at baseline. Personality was assessed using the NEO-FFI. This instrument measures five dimensions of personality. A hierarchical logistic regression was carried out to test for significant predictors of remittance. Further a multiple regression analysis was used to investigate variables predictive of changes on the Hamilton Depression Rating Scale as dependent variable.
RESULTS: Univariate analysis showed a significant relationship of outcome with severity, duration of index episode, and use of medical services (UMS). None of the personality variables was predictive of outcome. Regression analyses showed that these disease related variables each uniquely predicted outcome, but that personality factors did not significantly contribute to the prediction model. LIMITATIONS: The study was carried out in secondary and tertiary care centers and may not be generalizable to other populations. Personality dimensions were assessed with a self-report instrument and may be prone to bias.
CONCLUSIONS: Severity and duration of the index episode, and to a lesser extent, UMS, and not personality factors, predict outcome in the short term treatment of MDD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17467059     DOI: 10.1016/j.jad.2007.03.010

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  21 in total

1.  Moderators of fluoxetine treatment response for children and adolescents with comorbid depression and substance use disorders.

Authors:  Matthew E Hirschtritt; Maria E Pagano; Kelly M Christian; Nora K McNamara; Robert J Stansbrey; Jacqui Lingler; Jon E Faber; Christine A Demeter; Denise Bedoya; Robert L Findling
Journal:  J Subst Abuse Treat       Date:  2011-11-23

2.  Clinical and demographic predictors of improvement during duloxetine treatment in patients with major depression: an open-label study.

Authors:  Elena Di Nasso; Alberto Chiesa; Alessandro Serretti; Diana De Ronchi; Claudio Mencacci
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

3.  Prognostic Value of Pathological Personality Traits for Treatment Outcome in Anxiety and Depressive Disorders: The Leiden Routine Outcome Monitoring Study.

Authors:  Wessel A van Eeden; Albert M van Hemert; Erik J Giltay; Philip Spinhoven; Edwin de Beurs; Ingrid V E Carlier
Journal:  J Nerv Ment Dis       Date:  2022-04-23       Impact factor: 1.899

4.  The DSM-IV definition of severity of major depression: inter-relationship and validity.

Authors:  V Lux; S H Aggen; K S Kendler
Journal:  Psychol Med       Date:  2010-01-08       Impact factor: 7.723

5.  Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression.

Authors:  Jay C Fournier; Robert J DeRubeis; Richard C Shelton; Steven D Hollon; Jay D Amsterdam; Robert Gallop
Journal:  J Consult Clin Psychol       Date:  2009-08

6.  Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis.

Authors:  Pim Cuijpers; Marit Sijbrandij; Sander L Koole; Gerhard Andersson; Aartjan T Beekman; Charles F Reynolds
Journal:  World Psychiatry       Date:  2014-02       Impact factor: 49.548

Review 7.  The effect of interpersonal psychotherapy and other psychodynamic therapies versus 'treatment as usual' in patients with major depressive disorder.

Authors:  Janus Christian Jakobsen; Jane Lindschou Hansen; Erik Simonsen; Christian Gluud
Journal:  PLoS One       Date:  2011-04-27       Impact factor: 3.240

Review 8.  The effectiveness of individual interpersonal psychotherapy as a treatment for major depressive disorder in adult outpatients: a systematic review.

Authors:  Madelon L J M van Hees; Thomas Rotter; Tim Ellermann; Silvia M A A Evers
Journal:  BMC Psychiatry       Date:  2013-01-11       Impact factor: 3.630

9.  Observing the determinants of the psychotherapeutic process in depressive disorders. A clinical case study within a psychodynamic approach.

Authors:  Osmano Oasi
Journal:  Front Psychol       Date:  2015-04-21

10.  Neurofeedback as a treatment for major depressive disorder--a pilot study.

Authors:  Frenk Peeters; Mare Oehlen; Jacco Ronner; Jim van Os; Richel Lousberg
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.